Trial watch: dendritic cell vaccination for cancer immunotherapy

Dendritic- cells (DCs) have received considerable attention as potential targets for the development of anticancer vaccines. DC-based anticancer vaccination relies on patient-derived DCs pulsed with a source of tumor-associated antigens (TAAs) in the context of standardized maturation-cocktails, fol...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncoimmunology
Asıl Yazarlar: Sprooten, Jenny, Ceusters, Jolien, Coosemans, An, Agostinis, Patrizia, De Vleeschouwer, Steven, Zitvogel, Laurence, Kroemer, Guido, Galluzzi, Lorenzo, Garg, Abhishek D.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Taylor & Francis 2019
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6791419/
https://ncbi.nlm.nih.gov/pubmed/31646087
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2019.1638212
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller